Video Latest - ecancer

Added ibrutinib in first-line CLL treatment

Dr Nitin Jain - MD Anderson Cancer Center, Houston, USA

11 Dec 2017

T cell therapy for ALL

Dr Max Topp - University of Wurzburg, Wurzburg, Germany

11 Dec 2017

Immunosuppressive therapy in myelodysplastic syndrome

Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA

11 Dec 2017

The ACE-LY-004 study of acalabrutinib monotherapy for mantle cell lymphoma

Dr Michael Wang - MD Anderson Cancer Center, Houston, USA

11 Dec 2017

Why we are not ready for personalised medicine

Prof Tito Fojo - Columbia University, New York, USA

11 Dec 2017

Genetically profiling entire populations, starting with Estonia

Dr Tonu Esko - Estonian Biobank, Estonian Genome Center, University of Tartu, Tartu, Estonia

11 Dec 2017

Hypomethylating agents for relapsed and refractory acute myeloid leukaemia

Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA

$Hypomethylating agents for relapsed and refractory acute myeloid leukaemia ( Dr Maximilian Stahl - Yale Cancer Center, New Haven, USA )$

11 Dec 2017

How does ancestry affect your health?

Dr Eimear Kenny - Icahn School of Medicine at Mount Sinai, New York, USA

11 Dec 2017

Neuroblastoma and cell communication networks

Prof Walter Kolch - Systems Biology Ireland, UCD, Dublin, Ireland

11 Dec 2017

Personalised medicine differs from precision medicine

Prof Christine Chomienne - INCa, Paris, France

11 Dec 2017

Approaches to screening and early detection across Europe

Tit Albreht - Institute of Public Health, Ljubliana, Slovenia

11 Dec 2017

Connecting personalised medicine research in Canada with Europe

Dr Etienne Richer - CIHR Institute of Genetics, Montreal, Canada

11 Dec 2017

Video